Cargando…

Incretin Mimetics Restore the ER-Mitochondrial Axis and Switch Cell Fate Towards Survival in LUHMES Dopaminergic-Like Neurons: Implications for Novel Therapeutic Strategies in Parkinson’s Disease

BACKGROUND: Parkinson’s disease (PD) is a progressive neurodegenerative movement disorder that afflicts more than 10 million people worldwide. Available therapeutic interventions do not stop disease progression. The etiopathogenesis of PD includes unbalanced calcium dynamics and chronic dysfunction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panagaki, Theodora, Randi, Elisa B., Szabo, Csaba, Hölscher, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657688/ https://www.ncbi.nlm.nih.gov/pubmed/37718851 http://dx.doi.org/10.3233/JPD-230030

Ejemplares similares

Liraglutide restores chronic ER stress, autophagy impairments and apoptotic signalling in SH-SY5Y cells
por: Panagaki, Theodora, et al.
Publicado: (2017)

Role of 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation and Cellular Bioenergetics in Human Down Syndrome Fibroblasts
por: Panagaki, Theodora, et al.
Publicado: (2020)

Role of Hydrogen Sulfide and 3-Mercaptopyruvate Sulfurtransferase in the Regulation of the Endoplasmic Reticulum Stress Response in Hepatocytes
por: Panagaki, Theodora, et al.
Publicado: (2020)

Overproduction of H(2)S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down syndrome
por: Panagaki, Theodora, et al.
Publicado: (2019)

Physiological concentrations of cyanide stimulate mitochondrial Complex IV and enhance cellular bioenergetics
por: Randi, Elisa B., et al.
Publicado: (2021)

A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis
por: Smirnova, L., et al.
Publicado: (2015)

Role of the cystathionine β-synthase / H(2)S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome
por: Panagaki, Theodora, et al.
Publicado: (2022)

Inhibition of the 3-mercaptopyruvate sulfurtransferase—hydrogen sulfide system promotes cellular lipid accumulation
por: Casili, Giovanna, et al.
Publicado: (2022)

Transcriptome and Proteome Analysis in LUHMES Cells Overexpressing Alpha-Synuclein
por: Höllerhage, Matthias, et al.
Publicado: (2022)

The Influence of Incretin Mimetics on Cardiovascular Risk Factors in Diabetes
por: Kinalska, Ida, et al.
Publicado: (2012)

mitoLUHMES: An Engineered Neuronal Cell Line for the Analysis of the Motility of Mitochondria
por: Stępkowski, Tomasz M., et al.
Publicado: (2016)

Metabolic Effects of the Incretin Mimetic Exenatide in the Treatment of Type 2 Diabetes
por: Schnabel, Catherine A, et al.
Publicado: (2006)

Incretin Mimetics: Promising New Therapeutic Options in the Treatment of Type 2 Diabetes
por: Gleeson, Jeremy M., et al.
Publicado: (2005)

LUHMES Cells: Phenotype Refinement and Development of an MPP(+)-Based Test System for Screening Antiparkinsonian Drugs
por: Beliakov, Sergei V., et al.
Publicado: (2023)

Anti-atherosclerotic effect of incretin mimetics: a meta-analysis of randomized controlled trials
por: Barbarawi, Mahmoud, et al.
Publicado: (2018)

Role of Incretin Axis in Inflammatory Bowel Disease
por: Duan, Lihua, et al.
Publicado: (2017)

Development of a physiologically relevant and easily scalable LUHMES cell-based model of G2019S LRRK2-driven Parkinson's disease
por: Calamini, Barbara, et al.
Publicado: (2021)

Optical Control of Insulin Secretion Using an Incretin Switch
por: Broichhagen, Johannes, et al.
Publicado: (2015)

Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review
por: Hansen, Katrine B, et al.
Publicado: (2010)

GLP-1R signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimetics
por: Wright, Shane C., et al.
Publicado: (2023)

How should we think about the unprecedented weight loss efficacy of incretin-mimetic drugs?
por: Gou, Yang, et al.
Publicado: (2023)

Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells
por: Höllerhage, Matthias, et al.
Publicado: (2017)

Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury
por: Bader, Miaad, et al.
Publicado: (2020)

The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons
por: Lu, Xi, et al.
Publicado: (2014)

An Update on Gene Therapy Approaches for Parkinson’s Disease: Restoration of Dopaminergic Function
por: Van Laar, Amber D., et al.
Publicado: (2021)

Incretin Concepts
por: Bloomgarden, Zachary T.
Publicado: (2010)

Inflammation and incretins
por: Hatwal, Amitabh
Publicado: (2012)

IL-6-Mediated Upregulated miRNAs in Extracellular Vesicles Derived from Lund Human Mesencephalic (LUHMES) Cells: Effects on Astrocytes and Microglia
por: Nishi, Kento, et al.
Publicado: (2023)

Cell-penetrating, antioxidant SELENOT mimetic protects dopaminergic neurons and ameliorates motor dysfunction in Parkinson's disease animal models
por: Alsharif, Ifat, et al.
Publicado: (2020)

Hypoxia mimetics restore bone biomineralisation in hyperglycaemic environments
por: Rezaei, Azadeh, et al.
Publicado: (2022)

Overproduction of hydrogen sulfide, generated by cystathionine β-synthase, disrupts brain wave patterns and contributes to neurobehavioral dysfunction in a rat model of down syndrome
por: Panagaki, Theodora, et al.
Publicado: (2022)

GIP: An Inconsequential Incretin or Not?
por: Pratley, Richard E.
Publicado: (2010)

Pleiotropic effects of incretins
por: Gupta, Vishal
Publicado: (2012)

Incretin-based therapies
por: Stonehouse, Anthony H, et al.
Publicado: (2012)

A dopaminergic switch for fear to safety transitions
por: Luo, Ray, et al.
Publicado: (2018)

Switching from systemic steroids to ciclesonide restores the hypothalamic pituitary-adrenal axis
por: Marczak, Jerzy, et al.
Publicado: (2014)

Midbrain dopaminergic neuron fate specification: Of mice and embryonic stem cells
por: Gale, Emily, et al.
Publicado: (2008)

Prevalence of Incretin-Mimetic and Sodium-Glucose-Transporter-2-Inhibitor Therapy in German Hospitalized Type-2 Diabetics Following Myocardial Revascularization: An Observational Study
por: Pliquett, Rainer U., et al.
Publicado: (2020)

Effect of Glycemia on Plasma Incretins and the Incretin Effect During Oral Glucose Tolerance Test
por: Salehi, Marzieh, et al.
Publicado: (2012)

Methylation reactions at dopaminergic nerve endings, serving as biological off-switches in managing dopaminergic functions
por: Charlton, Clivel G.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8cg7vhdnrpt31ubush5398irmn